Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Curley

Showing results (351-360 of 391) with videos related to

Pageof 40
Sort By:
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 6, 2012
Improved long-term survival after major resection for hepatocellular carcinoma: a multicenter analysis based on a new definition of major hepatectomyAndreas Andreou, Jean-Nicolas Vauthey, Daniel Cherqui, et al.
American Journal of Clinical Oncology|June 7, 2006
Retrospective study of capecitabine and celecoxib in metastatic colorectal cancer: potential benefits and COX-2 as the common mediator in pain, toxicities and survival?Edward H Lin, Steven A Curley, Christopher C Crane, et al.
Cancer|July 27, 2004
Oral capecitabine for the treatment of hepatocellular carcinoma, cholangiocarcinoma, and gallbladder carcinomaYehuda Z Patt, Manal M Hassan, Alvaro Aguayo, et al.
Cancer|July 4, 2013
Modified cisplatin/interferon α-2b/doxorubicin/5-fluorouracil (PIAF) chemotherapy in patients with no hepatitis or cirrhosis is associated with improved response rate, resectability, and survival of initially unresectable hepatocellular carcinomaAhmed O Kaseb, Junichi Shindoh, Yehuda Z Patt, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|November 9, 2004
Hepatitis serology predicts tumor and liver-disease characteristics but not prognosis after resection of hepatocellular carcinomaTimothy M Pawlik, Ronnie T Poon, Eddie K Abdalla, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 13, 2007
Systemic chemotherapy and two-stage hepatectomy for extensive bilateral colorectal liver metastases: perioperative safety and survivalYun Shin Chun, Jean-Nicolas Vauthey, Dario Ribero, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|July 21, 2021
Use of human tissue stem cell-derived organoid cultures to model enterohepatic circulationSarah E Blutt, Sue E Crawford, Carolyn Bomidi, et al.
Annals of Surgical Oncology|August 31, 2012
Morbidity of staged proctectomy after hepatectomy for colorectal cancer: a matched case-control analysisChing-Wei D Tzeng, Thomas A Aloia, Jean-Nicolas Vauthey, et al.
Annals of Surgical Oncology|May 26, 2005
Is hepatic resection for large or multinodular hepatocellular carcinoma justified? Results from a multi-institutional databaseKelvin K Ng, Jean-Nicolas Vauthey, Timothy M Pawlik, et al.
Surgery|December 14, 2001
Evaluation and surgical resection of adrenal masses in patients with a history of extra-adrenal malignancyJ T Lenert, C C Barnett, A P Kudelka, et al.
Pageof 40

Showing results (351-360 of 391) with videos related to

Sort By:
Pageof 40
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 6, 2012
Improved long-term survival after major resection for hepatocellular carcinoma: a multicenter analysis based on a new definition of major hepatectomyAndreas Andreou, Jean-Nicolas Vauthey, Daniel Cherqui, et al.
American Journal of Clinical Oncology|June 7, 2006
Retrospective study of capecitabine and celecoxib in metastatic colorectal cancer: potential benefits and COX-2 as the common mediator in pain, toxicities and survival?Edward H Lin, Steven A Curley, Christopher C Crane, et al.
Cancer|July 27, 2004
Oral capecitabine for the treatment of hepatocellular carcinoma, cholangiocarcinoma, and gallbladder carcinomaYehuda Z Patt, Manal M Hassan, Alvaro Aguayo, et al.
Cancer|July 4, 2013
Modified cisplatin/interferon α-2b/doxorubicin/5-fluorouracil (PIAF) chemotherapy in patients with no hepatitis or cirrhosis is associated with improved response rate, resectability, and survival of initially unresectable hepatocellular carcinomaAhmed O Kaseb, Junichi Shindoh, Yehuda Z Patt, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|November 9, 2004
Hepatitis serology predicts tumor and liver-disease characteristics but not prognosis after resection of hepatocellular carcinomaTimothy M Pawlik, Ronnie T Poon, Eddie K Abdalla, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 13, 2007
Systemic chemotherapy and two-stage hepatectomy for extensive bilateral colorectal liver metastases: perioperative safety and survivalYun Shin Chun, Jean-Nicolas Vauthey, Dario Ribero, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|July 21, 2021
Use of human tissue stem cell-derived organoid cultures to model enterohepatic circulationSarah E Blutt, Sue E Crawford, Carolyn Bomidi, et al.
Annals of Surgical Oncology|August 31, 2012
Morbidity of staged proctectomy after hepatectomy for colorectal cancer: a matched case-control analysisChing-Wei D Tzeng, Thomas A Aloia, Jean-Nicolas Vauthey, et al.
Annals of Surgical Oncology|May 26, 2005
Is hepatic resection for large or multinodular hepatocellular carcinoma justified? Results from a multi-institutional databaseKelvin K Ng, Jean-Nicolas Vauthey, Timothy M Pawlik, et al.
Surgery|December 14, 2001
Evaluation and surgical resection of adrenal masses in patients with a history of extra-adrenal malignancyJ T Lenert, C C Barnett, A P Kudelka, et al.
Pageof 40